March 24 (Reuters) - Fever-Tree Drinks reported a 16% drop in annual profit on Tuesday after booking a one-off ...

Fever-Tree reported a 16% annual profit drop hit by a disputed £2.8M UK packaging levy and margin pressure from its Molson ...

The premium drinks brand has seen its UK revenue fall as a result of costs associated with Extended Producer Responsibility and disruption from the US arm’s partnership with Molson Coors.

Profits at Fever-Tree have taken a hit as the group recognised the potential impact of the government's packaging tax and ...

Fevertree Drinks (AIM:FEVR), the premium mixer brand, posted a 2% rise in full-year revenue to £375 million but saw profits ...

Fevertree reported its 2025 earnings today and the investors liked what they saw. So is this a share to consider buying while ...

Fevertree has launched a legal challenge against the Environment Agency over its application of a sustainability packaging ...

Cosmetics giant Estée Lauder (EL) was also trending on Tuesday morning, after the company confirmed that it is in discussions ...

Enzymes that play a crucial role in the production of the malaria drug quinine and other important cinchona alkaloids have ...

Fever-Tree Drinks reported a 16% drop in annual profit on Tuesday after booking a one-off £2.8 million (€3.2 million) charge.

Fevertee, which completed a GBP100 million share buyback programme in 2025, commenced a further GBP30 million buyback last ...

Fever-Tree has reported “strong strategic progress” in its full-year 2025 results, with growth accelerating in the second ...